This service supports the establishment of a microbiome similar to that of breastfed infants, immune system development, gut microbiome, optimal developmental trajectory, and improved outcomes between breastfed and non-breastfed infants. The aim is to narrow the gap.
“Our partnership with Lallemand Health Solutions is an important milestone in the early nutrition market,” said James Young, vice president of early nutrition at dsm-firmenich. “By leveraging HMO and Lallemand’s deep understanding of world-class probiotics, we are poised to set a new standard for synbiotics in infant nutrition.”
“Our Expert’Biotic probiotic infant strain has been clinically documented in more than 1,600 infants and has proven to be safe and effective,” said Isabelle Champier, vice president of sales and marketing for Lallemand Health Solutions. It has been proven,” he added.
Combining these with DSM-Firmenich’s HMOs has created a solution that can establish a strong foundation for infant health by supporting microbiome development during the critical period of early childhood, she explained. .
HMOs and probiotics
The most important changes in the gut microbiome occur during the first year of life. During this period, probiotics contribute to the infant’s microbiome and help lay the foundation for healthy growth and development.
A balanced microbiome composition and early childhood development contributes to a variety of health outcomes, including improved intestinal barrier function against opportunistic microorganisms, proper development of the baby’s immune system, and proper functioning of the gut-brain axis and its effects. associated with benefits. developing brain.
HMOs, the third largest solid component of breast milk, act as prebiotic substances that promote the growth of beneficial bacteria in the infant’s intestine and support the development of a healthy microbiome and immune system.
Studies have shown that certain HMOs can selectively promote the growth of specific probiotic strains and enhance the production of target metabolites in a range of gut health, natural defenses, cognition, growth, and development. I am.
“When HMOs are combined with probiotics, new synergistic synbiotic solutions emerge that enhance the benefits of the individual components,” Champier said.
By combining HMOs and probiotics that use HMOs as a substrate, dsm-firmenich and Lallemand Health Solutions have developed a unique synergistic combination that promotes infant health and optimal development.
The rise of synbiotics
Ewa Hudson, Director of Insights at Lumina Intelligence, recently told NutraIngredients that synbiotic solutions are becoming more popular in the biotics market thanks to the recognition that combinations of biotics can improve probiotic survival and survival within the gastrointestinal tract. said that it is increasing.
According to data from Lumina Intelligence, synbiotics currently account for 38% of biotic SKUs in Europe and overtook (pure) probiotic supplements in online engagement in the first half of 2023. The global synbiotic products market is projected to grow at a CAGR of 7.5% from 2023 to 2030.
